On September 25, 2018 Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, reported that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the following investor conferences (Press release, Leap Therapeutics, SEP 25, 2018, View Source;p=RssLanding&cat=news&id=2368738 [SID1234529666]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Ladenburg Thalmann 2018 Healthcare Conference in New York City on Tuesday, October 2, 2018 at 11:00 a.m. ET.
The Cantor Fitzgerald 2018 Global Healthcare Conference in New York City on Wednesday, October 3, 2018 at 8:00 a.m. ET.
These presentations will be webcast live and may be accessed on the Investors page of the company’s website at www.investors.leaptx.com, where a replay of the event will also be available for a limited time.